Development of Sustainable Applications for iPSCDerived Cells Beyond Traditional Disease Indications

  • Robust, simpler manufacturing technology with a focus on scalable and streamlined approaches
  • Better understanding of in vivo cell behavior to improve insight into cell performance and persistence
  • Lowering overall cost by reducing cost of goods and improving accessibility
  • Considering hES alongside hiPS cells to evaluate their respective roles and applications